Is a pan-European approach the way forward for health technology assessment?
This article was originally published in Clinica
Executive Summary
Health technology assessment (HTA) and its increased influence on healthcare payers' decision-making process has a potentially profound impact on medtech manufacturers. In this article, Dr Mark Charny of UK consultancy Translucency examines the different components of HTA in Europe and whether a pan-EU HTA system is viable, as well as the growing importance of evidence-based medicine to help define the most effective clinical care